Docetaxel and Oxaliplatin Combination With Locally Advanced or Metastatic Biliary Tract Cancer
Status:
Unknown status
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
1. Goals
- The primary goal of this phase II trial is to:
evaluate the response rate of combination chemotherapy with docetaxel and oxaliplatin in
patients with locally advanced or metastatic BTC as first-line therapy
Secondary goals are to:evaluate the treatment-related toxicities of this combination,
investigate progression-free survival (PFS) and overall survival (OS) in this population
2. Design
The proposed clinical trial is an open label, non-comparative, multicenter phase II trial
according to the two stage testing design by Simon.22